231 related articles for article (PubMed ID: 23054396)
1. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5.
Romagnoli M; Belguise K; Yu Z; Wang X; Landesman-Bollag E; Seldin DC; Chalbos D; Barillé-Nion S; Jézéquel P; Seldin ML; Sonenshein GE
Cancer Res; 2012 Dec; 72(23):6268-78. PubMed ID: 23054396
[TBL] [Abstract][Full Text] [Related]
2. Activation of NF-κB by TOPK upregulates Snail/Slug expression in TGF-β1 signaling to induce epithelial-mesenchymal transition and invasion of breast cancer cells.
Lee YJ; Park JH; Oh SM
Biochem Biophys Res Commun; 2020 Sep; 530(1):122-129. PubMed ID: 32828273
[TBL] [Abstract][Full Text] [Related]
3. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T
PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975
[TBL] [Abstract][Full Text] [Related]
4. TRPC1/3/6 inhibition attenuates the TGF-β1-induced epithelial-mesenchymal transition in gastric cancer via the Ras/Raf1/ERK signaling pathway.
Ge P; Wei L; Zhang M; Hu B; Wang K; Li Y; Liu S; Wang J; Li Y
Cell Biol Int; 2018 Aug; 42(8):975-984. PubMed ID: 29570903
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
Cho KH; Yu SL; Cho DY; Park CG; Lee HY
BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
8. TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling.
Lee YJ; Park JH; Oh SM
Biochem Biophys Res Commun; 2020 Jan; 522(1):270-277. PubMed ID: 31757421
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of invasion and epithelial-mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression.
Lv M; Li Y; Ji MH; Zhuang M; Tang JH
Mol Med Rep; 2014 Jul; 10(1):341-6. PubMed ID: 24756435
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
13. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
14. Targeting specificity protein 1 with miR-128-3p overcomes TGF-β1 mediated epithelial-mesenchymal transition in breast cancer: An in vitro study.
Nalla LV; Gondaliya P; Kalia K; Khairnar A
Mol Biol Rep; 2022 Jul; 49(7):6987-6996. PubMed ID: 35486287
[TBL] [Abstract][Full Text] [Related]
15. Baicalin and baicalein inhibit transforming growth factor-β1-mediated epithelial-mesenchymal transition in human breast epithelial cells.
Chung H; Choi HS; Seo EK; Kang DH; Oh ES
Biochem Biophys Res Commun; 2015 Mar; 458(3):707-713. PubMed ID: 25686495
[TBL] [Abstract][Full Text] [Related]
16. MiR-487a Promotes TGF-β1-induced EMT, the Migration and Invasion of Breast Cancer Cells by Directly Targeting MAGI2.
Ma M; He M; Jiang Q; Yan Y; Guan S; Zhang J; Yu Z; Chen Q; Sun M; Yao W; Zhao H; Jin F; Wei M
Int J Biol Sci; 2016; 12(4):397-408. PubMed ID: 27019625
[TBL] [Abstract][Full Text] [Related]
17. Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide.
Yu Z; Sato S; Trackman PC; Kirsch KH; Sonenshein GE
PLoS One; 2012; 7(3):e33287. PubMed ID: 22438909
[TBL] [Abstract][Full Text] [Related]
18. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
Li Y; Zhou X; Liu J; Gao N; Yang R; Wang Q; Ji J; Ma L; He Q
Life Sci; 2020 May; 248():117454. PubMed ID: 32088211
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 Induces EMT in Bovine Mammary Epithelial Cells Through the TGFβ1/Smad Signaling Pathway.
Chen Q; Yang W; Wang X; Li X; Qi S; Zhang Y; Gao MQ
Cell Physiol Biochem; 2017; 43(1):82-93. PubMed ID: 28848180
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.
Gao J; Yan Q; Wang J; Liu S; Yang X
J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
